Explore Treatments for Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)

PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) are conditions that cause a sudden and dramatic onset of symptoms such as obsessive-compulsive behaviors (OCD) or severely restricted eating in children usually before puberty. In addition to OCD or eating changes, children may experience mood swings or personality changes, anxiety, irritability, depression, motor or vocal tics, sleep disturbances, trouble with schoolwork or memory and difficulty separating from family. The main difference between the two is the trigger. PANS can be caused by various infections (viral or bacterial), immune system issues, or even environmental factors. PANDAS is a specific type of PANS that’s triggered by a strep infection, like strep throat or scarlet fever. Symptoms of PANS/PANDAS often appear suddenly, can be severe, and may come and go over time. Researchers believe that in some children, the immune system mistakenly attacks the brain, causing inflammation that affects behavior and movement. Treatment focuses on addressing the underlying infection or immune response, managing behavioral and neurological symptoms and supporting the child’s overall health and emotional well-being. A healthcare provider can help families develop a personalized care plan, which may include antibiotics, anti-inflammatory medications, therapy, and other supportive interventions.

Treatments Offered by CSI

Immunoglobulins are derived from pooled human plasma collected from thousands of carefully screened donors. The plasma is rigorously processed and purified to ensure product safety and integrity. Intravenous immunoglobulin (IVIG) contains antibodies that provide broad protection against a wide range of bacteria and viruses. It is administered intravenously and is primarily used to treat three categories of conditions: primary immunodeficiency diseases, autoimmune disorders, and certain neurological conditions. 

  • Alyglo 10% 
  • Asceniv 10% 
  • Bivigam 10% 
  • Gammagard S/D 
  • Gammagard Liquid 10% 
  • Gammaked 10% 
  • Gamunex-C 10% 
  • Gammaplex 5% 
  • Gammaplex 10% 
  • Octagam 5% 
  • Octagam 10% 
  • Panzyga 10% 
  • Privigen 10% 
  • Yimmugo 10% 

Immunoglobulins are derived from pooled human plasma collected from thousands of carefully screened donors. The plasma undergoes rigorous processing and purification to ensure the highest standards of safety and product integrity. Subcutaneous immunoglobulin (SCIG) contains antibodies that offer broad protection against a wide range of bacteria and viruses. It is administered under the skin (subcutaneously) and is primarily used to treat primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy (CIDP). SCIG is also being studied in clinical trials for use in additional conditions. 

  • Cutaquig 16.5%  
  • Cuvitru 20% 
  • Gammagard Liquid 10% 
  • Gammaked 10% 
  • Gamunex-C 10% 
  • Hizentra 20% 
  • HyQvia 10% (facilitated SCIG)  
  • Xembify 20%